Genitourinary Cancers: Current Research and New Treatments

Chapter 1

In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses current research in genitourinary cancers, including biomarkers for response to chemotherapy among genitourinary cancers.

Chapter 2

Bladder Cancer: PD-L1 Inhibitors Changing the Standard of Care

In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the role PD-L1 inhibitors are starting to play in the treatment of genitourinary cancers, including several recent approvals in bladder cancer.

Chapter 3

Bladder Cancer: The Emergence of Personalized Medicine

In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the emerging role of personalized therapy in bladder cancer care.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs